Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 9,120.00
-560.00 (-5.79%)
Mar 23, 2026, 3:30 PM KST
-22.71% (1Y)
| Market Cap | 116.35B -33.8% |
| Revenue (ttm) | 19.02B +224.2% |
| Net Income | 13.68B |
| EPS | 227.41 |
| Shares Out | 12.02M |
| PE Ratio | 42.57 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100,732 |
| Average Volume | 114,329 |
| Open | 9,390.00 |
| Previous Close | 9,680.00 |
| Day's Range | 9,120.00 - 9,680.00 |
| 52-Week Range | 9,000.00 - 20,000.00 |
| Beta | 0.76 |
| RSI | 34.64 |
| Earnings Date | Feb 27, 2026 |